Skip to content

Clinical trials

Recruiting Phase 2/3 Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2/3 Status: Recruiting Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20221
20236
20242
202510
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK8
Monash University5
AbbVie2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
CatalYm GmbH1
Celgene1
KU Leuven1
M.D. Anderson Cancer Center1
McMaster University1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms23
Hematologic Neoplasms8
Neoplasms by Histologic Type7
Neoplasms by Site7
Lymphoma6
Infections5
Leukemia5
Lymphoproliferative Disorders5
Neoplasms, Plasma Cell5
Colorectal Neoplasms4

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.